Skip to Main Content

Author Details

Michael D Taylor
The Hospital for Sick Children
1995
432
99
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36323321Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity.Neuron2023
36240479Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset.J Clin Oncol2023
36323321Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity.Neuron2023
37576901Linked-read based analysis of the medulloblastoma genome.Front Oncol2023
37287693A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial <i>ZFTA-</i>fused ependymoma.Neurooncol Adv2023
37341142The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival.Mol Oncol2023
370855393D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Nat Commun2023
36649564Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma.Cancer Discov2023
37463901Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer.Nat Commun2023
36757527Outcomes following management of relapsed pediatric posterior fossa ependymoma in the molecular era.J Neurooncol2023
37322748Magnetization Transfer Contrast - Is it Sensitive Enough to Differentiate Demyelination from Axonal Loss?Neurol India2023
36696605The Burden of Surviving Childhood Medulloblastoma: A Population-Based, Matched Cohort Study in Ontario, Canada.J Clin Oncol2023
37379234Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.Neuro Oncol2023
37115469Correction to: Outcomes following management of relapsed pediatric posterior fossa ependymoma in the molecular era.J Neurooncol2023
36849558A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis.Nat Cell Biol2023
37503309Synapse-specific diversity of distinct postsynaptic GluN2 subtypes defines transmission strength in spinal lamina I.Front Synaptic Neurosci2023
37503309Synapse-specific diversity of distinct postsynaptic GluN2 subtypes defines transmission strength in spinal lamina I.Front Synaptic Neurosci2023
37576901Linked-read based analysis of the medulloblastoma genome.Front Oncol2023
37322748Magnetization Transfer Contrast - Is it Sensitive Enough to Differentiate Demyelination from Axonal Loss?Neurol India2023
370855393D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma.Nat Commun2023
37287693A multi-institutional retrospective pooled outcome analysis of molecularly annotated pediatric supratentorial <i>ZFTA-</i>fused ependymoma.Neurooncol Adv2023
37115469Correction to: Outcomes following management of relapsed pediatric posterior fossa ependymoma in the molecular era.J Neurooncol2023
37379234Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.Neuro Oncol2023
37341142The LIN28B-let-7-PBK pathway is essential for group 3 medulloblastoma tumor growth and survival.Mol Oncol2023
37463901Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer.Nat Commun2023
36696605The Burden of Surviving Childhood Medulloblastoma: A Population-Based, Matched Cohort Study in Ontario, Canada.J Clin Oncol2023
36849558A neurodevelopmental epigenetic programme mediated by SMARCD3-DAB1-Reelin signalling is hijacked to promote medulloblastoma metastasis.Nat Cell Biol2023
36649564Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma.Cancer Discov2023
36757527Outcomes following management of relapsed pediatric posterior fossa ependymoma in the molecular era.J Neurooncol2023
36240479Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset.J Clin Oncol2023
34272868Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse.Neuro Oncol2022
35831316The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors.Nat Commun2022
36219398Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.Cancer Res2022
35618754Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapy.Nat Commun2022
36131014Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
35853870A brain precursor atlas reveals the acquisition of developmental-like states in adult cerebral tumours.Nat Commun2022
35352030Amplifying natural antitumor immunity for personalized immunotherapy.Cell Res2022
36450980Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis.Nature2022
36446943Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation.Nature2022
36503484Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data.BMC Cancer2022
36471070K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas.Nat Genet2022
36524349Correction: PINK1 Is a Negative Regulator of Growth and the Warburg Effect in Glioblastoma.Cancer Res2022
34272868Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse.Neuro Oncol2022
34992263Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency.Nat Med2022
35031778The biology of ependymomas and emerging novel therapies.Nat Rev Cancer2022
34907396Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma.Nat Neurosci2022
34850171Radiomic signatures of posterior fossa ependymoma: Molecular subgroups and risk profiles.Neuro Oncol2022
35174975A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.EMBO Mol Med2022
34702771Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study.Clin Cancer Res2022
34418362The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children (MUSIC): Design and Objectives.Am Heart J2022
  • 1 - 50 of 864

Recommended Authors

St. Jude Children's Research Hospital
Career Start Year 2018
Number of shared co-authors 65
Children's Hospital of Philadelphia
Career Start Year 2017
Number of shared co-authors 25
College of Medicine, The Ohio State University
Career Start Year 2017
Number of shared co-authors 10
St. Jude Children's Research Hospital
Career Start Year 2017
Number of shared co-authors 25
University of Virginia
Career Start Year 2017
Number of shared co-authors 0
Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine
Career Start Year 2016
Number of shared co-authors 19
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 1
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 17
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 22
National Cancer Institute
Career Start Year 2013
Number of shared co-authors 38
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2012
Number of shared co-authors 33
Washington University
Career Start Year 2012
Number of shared co-authors 42
Institute for Genomic Medicine, Nationwide Children's Hospital
Career Start Year 2011
Number of shared co-authors 1
Feinberg School of Medicine, Northwestern University
Career Start Year 2011
Number of shared co-authors 7
University of California
Career Start Year 2010
Number of shared co-authors 8
University of California san francisco
Career Start Year 2010
Number of shared co-authors 37
University of Michigan-Ann Arbor
Career Start Year 2010
Number of shared co-authors 65
Maharaja Agrasen Medical College
Career Start Year 2009
Number of shared co-authors 36
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 27
Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 43
NewYork-Presbyterian Hospital - Weill Cornell Medicine
Career Start Year 2004
Number of shared co-authors 9
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 28
Kumamoto University Hospital
Career Start Year 2000
Number of shared co-authors 12
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 36
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 38
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 15
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 50
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 40
Institut Curie
Career Start Year 1994
Number of shared co-authors 35
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 14

Collaborators

Hospital for Sick Children
Co-authored papers 149
St Jude Children's Research Hospital
Co-authored papers 108
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 106
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 100
The Hospital for Sick Children
Co-authored papers 90
Hospital for Sick Children
Co-authored papers 87
The Hospital for Sick Children
Co-authored papers 80
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 75
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 72
The Hospital for Sick Children, University of Toronto
Co-authored papers 69
Co-authored papers 61
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 52
St Jude Children's Research Hospital
Co-authored papers 51
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 48
Hospital for Sick Children
Co-authored papers 45
Dana-Farber Cancer Institute
Co-authored papers 43
The Research Institute of the McGill University Health Centre, McGill University
Co-authored papers 41
Cumming School of Medicine, University of Calgary
Co-authored papers 39
University of Texas MD Anderson Cancer Center Houston
Co-authored papers 37
Arthur and Sonia Labatt Brain Tumor Research Centre, Hospital for Sick Children
Co-authored papers 36
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 36
German Cancer Research Center (DKFZ)
Co-authored papers 35
University of California san francisco
Co-authored papers 33
Institut Curie, PSL Research University
Co-authored papers 31
The Chinese University of Hong Kong, Prince of Wales Hospital
Co-authored papers 31
The Hospital for Sick Children
Co-authored papers 31
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 30
Co-authored papers 30
St. Jude Children's Research Hospital
Co-authored papers 30
University of Wollongong
Co-authored papers 29